Discontinued — last reported Q4 '25
Insmed Change in AR decreased by 50.6% to $38.19M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 812.4%, from -$5.36M to $38.19M. Over 4 years (FY 2021 to FY 2025), Change in AR shows an upward trend with a 81.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.
A significant increase may signal aggressive revenue recognition or collection issues, while a decrease suggests improved cash conversion cycles.
The net change in the balance of accounts receivable during the reporting period, representing the difference between cr...
Should track closely with revenue growth; significant deviations from revenue trends warrant investigation.
anet_change_in_accounts_receivable| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $789.00K | $1.02M | $5.24M | $1.80M | $4.99M | -$1.34M | $983.00K | $860.00K | $1.43M | $5.14M | $4.54M | -$2.96M | $4.04M | $35.00K | $11.82M | -$5.36M | $6.14M | $10.23M | $77.30M | $38.19M |
| QoQ Change | — | +29.3% | +414.0% | -65.7% | +177.3% | -127.0% | +173.1% | -12.5% | +66.4% | +259.0% | -11.7% | -165.2% | +236.5% | -99.1% | >999% | -145.4% | +214.6% | +66.5% | +655.9% | -50.6% |
| YoY Change | — | — | — | — | +531.9% | -231.8% | -81.3% | -52.2% | -71.3% | +482.2% | +361.3% | -443.6% | +182.0% | -99.3% | +160.6% | -81.4% | +52.2% | >999% | +554.1% | +812.4% |